{\rtf1\ansi\deff0
{\fonttbl{\f0\fswiss Arial;}{\f1\froman Times New Roman;}}
{\colortbl;\red0\green0\blue0;\red44\green62\blue80;\red127\green140\blue141;}
\f1\fs24

{\b\fs32\cf2 Research to evaluate safety and impact of long COVID intervention with Ensitrelvir for National Cohort (RESILIENCE Study): A protocol for a randomized, double-blind, placebo-controlled trial.}
\par\par

{\b Paper ID:} PMC12582476
\par
{\b Authors:} Konishi K, Yamamoto S, Sada RM, Asano K, Onozuka D, Tanaka S, Miyazawa S, Kinoshita M, Kutsuna S.
\par
{\b Journal:} Unknown
\par
{\b Year:} 2025
\par
{\b DOI:} 10.1371/journal.pone.0335609
\par\par

{\b\fs28 Abstract}
\par
<h4>Trial registration</h4>This study was registered with the Japan Registry of Clinical Trials on February 16, 2024 (jRCTs051230184, https://jrct.mhlw.go.jp/en-latest-detail/jRCTs051230184).
\par\par

{\i\fs18\cf3 Downloaded from Europe PMC | Full metadata available in JSON file}
}